Federal grants to Eclipse Regenesis, Inc.
Eclipse Regenesis, Inc. in Mountain View, California received $4.4 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $2.6 million. In fiscal 2025 it was awarded $1.4 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.4 million
- Awards3
- Awarded in FY 2025$1.4 million
- Largest award$2.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $679,221 |
| FY 2022 | 1 | $546,853 |
| FY 2023 | 2 | $1.8 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 2 | $1.4 million |
Programs that fund Eclipse Regenesis, Inc.
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.6 million |
| Technology, Innovation, and Partnerships | 1 | $1.5 million |
| Engineering | 1 | $256,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 1 | $2.6 million |
| National Science Foundation | 2 | $1.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Intestinal lengthening via distraction enterogenesis for the treatment of short bowel syndrome - project summary short bowel syndrome (SBS) is a rare, chronic, and devastating malabsorption condition where patients are unable to absorb enough nutrients naturally to sustain life. This condition is du | Diabetes, Digestive, and Kidney Diseases Extramural Research | July 9, 2021 | $2.6 million |
| Sbir phase II: endoluminal fixation of a distraction enterogenesis device -the broader impact/commercial potential of this small business innovation research (SBIR) phase II project is the advancement of an innovative therapy for short bowel syndrome. Compared to current non-curative treatments that | Technology, Innovation, and Partnerships | April 19, 2023 | $1.5 million |
| Sbir phase i: endoluminal fixation of a distraction enterogenesis device | Engineering | December 21, 2020 | $256,000 |
Questions people ask
How much federal grant money does Eclipse Regenesis, Inc. get?
$4.4 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Eclipse Regenesis, Inc. the most?
The Department of Health and Human Services, with $2.6 million in 1 award. The National Science Foundation follow.
What is Eclipse Regenesis, Inc.'s largest federal grant?
$2.6 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on July 9, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Eclipse Regenesis, Inc.?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Technology, Innovation, and Partnerships and Engineering.
Other grant recipients in Mountain View
- Bay Area Environmental Research Institute
- Mitra Future Technologies, Inc.
- Seti Institute
- Neuropace Inc
- City of Mountain View
- Enspectra Health, Inc.
- Claria Medical, Inc
- Kinetic River Corp.
Largest federal grant recipients in California · Federal grants in California